Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Case report

Case report: a fatal case of disseminated adenovirus infection in a non-transplant adult haematology patient

Authors: Michael Joffe, Simon D. Wagner, Julian W. Tang

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

We report a fatal case of disseminated adenovirus infection in a non-transplant haematology adult patient with chronic lymphocytic leukaemia who had completed combination chemoimmunotherapy a few months before developing respiratory symptoms. In such non-transplant patients, monitoring for adenovirus in the blood is not routine. However, with adenoviruses, when there is a more peripheral (i.e. non-blood) site of infection such as the chest, serial adenovirus monitoring in blood for the duration of that illness may be warranted.

Case presentation

This case started with an initial bacterial chest infection that responded to treatment, followed by an adenovirus pneumonitis that disseminated to his blood a week later with levels of up to 92 million adenovirus DNA copies/ml. Despite prompt treatment with cidofovir, his respiratory function continued to deteriorate over the next two weeks and he was moved to intensive care. Intravenous immunoglobulin and ribavirin were subsequently added to his treatment. However, he died soon after this with a final adenovirus load of 20 million copies/ml in his blood.

Conclusions

We recommend that even in non-transplant haematology patients, where such patients present with an acute respiratory adenovirus infection, teams should consider checking the blood for adenovirus to check for signs of disseminated infection. The earlier this can be tested, the earlier treatment can be initiated (if adenovirus positive), which may produce more successful clinical outcomes.
Literature
2.
go back to reference Sanchez JL, Binn LN, Innis BL, Reynolds RD, Lee T, Mitchell-Raymundo F, Craig SC, Marquez JP, Shepherd GA, Polyak CS, Conolly J, Kohlhase KF. Epidemic of adenovirus-induced respiratory illness among US military recruits: epidemiologic and immunologic risk factors in healthy, young adults. J Med Virol. 2001;65(4):710–8.CrossRefPubMed Sanchez JL, Binn LN, Innis BL, Reynolds RD, Lee T, Mitchell-Raymundo F, Craig SC, Marquez JP, Shepherd GA, Polyak CS, Conolly J, Kohlhase KF. Epidemic of adenovirus-induced respiratory illness among US military recruits: epidemiologic and immunologic risk factors in healthy, young adults. J Med Virol. 2001;65(4):710–8.CrossRefPubMed
3.
go back to reference Kolavic-Gray SA, Binn LN, Sanchez JL, Cersovsky SB, Polyak CS, Mitchell-Raymundo F, Asher LV, Vaughn DW, Feighner BH, Innis BL. Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies. Clin Infect Dis. 2002;35(7):808–18.CrossRefPubMed Kolavic-Gray SA, Binn LN, Sanchez JL, Cersovsky SB, Polyak CS, Mitchell-Raymundo F, Asher LV, Vaughn DW, Feighner BH, Innis BL. Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies. Clin Infect Dis. 2002;35(7):808–18.CrossRefPubMed
4.
go back to reference Tate JE, Bunning ML, Lott L, Lu X, Su J, Metzgar D, Brosch L, Panozzo CA, Marconi VC, Faix DJ, Prill M, Johnson B, Erdman DD, Fonseca V, Anderson LJ, Widdowson MA. Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J Infect Dis. 2009;199(10):1419–26.CrossRefPubMed Tate JE, Bunning ML, Lott L, Lu X, Su J, Metzgar D, Brosch L, Panozzo CA, Marconi VC, Faix DJ, Prill M, Johnson B, Erdman DD, Fonseca V, Anderson LJ, Widdowson MA. Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J Infect Dis. 2009;199(10):1419–26.CrossRefPubMed
5.
go back to reference Hough R, Chetwood A, Sinfield R, Welch J, Vora A. Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2005;27(2):67–72.CrossRefPubMed Hough R, Chetwood A, Sinfield R, Welch J, Vora A. Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2005;27(2):67–72.CrossRefPubMed
6.
go back to reference Steiner I, Aebi C, Ridolfi Lüthy A, Wagner B, Leibundgut K. Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;50(3):647–9.CrossRefPubMed Steiner I, Aebi C, Ridolfi Lüthy A, Wagner B, Leibundgut K. Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;50(3):647–9.CrossRefPubMed
7.
go back to reference Lee YJ, Palomino-Guilen P, Babady NE, Lamson DM, St George K, Tang YW, Papanicolaou GA. Disseminated adenovirus infection in cancer patients presenting with focal pulmonary consolidation. J Clin Microbiol. 2014;52(1):350–3.CrossRefPubMedPubMedCentral Lee YJ, Palomino-Guilen P, Babady NE, Lamson DM, St George K, Tang YW, Papanicolaou GA. Disseminated adenovirus infection in cancer patients presenting with focal pulmonary consolidation. J Clin Microbiol. 2014;52(1):350–3.CrossRefPubMedPubMedCentral
8.
go back to reference Roch N, Salameire D, Gressin R, Morand P, Epaulard O, Pavese P, Brion JP, Stahl JP. Fatal adenoviral and enteroviral infections and an Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment in a patient with refractory Sézary syndrome. Scand J Infect Dis. 2008;40(4):343–6.CrossRefPubMed Roch N, Salameire D, Gressin R, Morand P, Epaulard O, Pavese P, Brion JP, Stahl JP. Fatal adenoviral and enteroviral infections and an Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment in a patient with refractory Sézary syndrome. Scand J Infect Dis. 2008;40(4):343–6.CrossRefPubMed
9.
go back to reference Veater J, Wong N, Stephenson I, Kirk-Granger H, Baxter LF, Cannon R, Wilson S, Atabani S, Sahota A, Bell D, Wiselka M, Tang JW. Resource impact of managing suspected Middle East respiratory syndrome patients in a UK teaching hospital. J Hosp Infect. 2017;95(3):280–5.CrossRefPubMed Veater J, Wong N, Stephenson I, Kirk-Granger H, Baxter LF, Cannon R, Wilson S, Atabani S, Sahota A, Bell D, Wiselka M, Tang JW. Resource impact of managing suspected Middle East respiratory syndrome patients in a UK teaching hospital. J Hosp Infect. 2017;95(3):280–5.CrossRefPubMed
10.
go back to reference Picardi M, Pane F, Quintarelli C, De Renzo A, Del Giudice A, De Divitiis B, Persico M, Ciancia R, Salvatore F, Rotoli B. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations. Haematologica. 2003;88(11):1296–303.PubMed Picardi M, Pane F, Quintarelli C, De Renzo A, Del Giudice A, De Divitiis B, Persico M, Ciancia R, Salvatore F, Rotoli B. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations. Haematologica. 2003;88(11):1296–303.PubMed
11.
go back to reference Power JP, El Chaar M, Temple J, Thomas M, Spillane D, Candotti D, Allain JP. HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted hepatitis B virus. J Hepatol. 2010;53(4):780–7.CrossRefPubMed Power JP, El Chaar M, Temple J, Thomas M, Spillane D, Candotti D, Allain JP. HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted hepatitis B virus. J Hepatol. 2010;53(4):780–7.CrossRefPubMed
12.
go back to reference Toscanini F, De Leo P, Calcagno G, Malfatti F, Grasso A, Anselmo M. Hepatitis B Reactivation in a HBsAg-negative, HBcAb-positive patient receiving Fludarabine for the treatment of chronic lymphocytic Leukaemia. Case Reports Hepatol. 2011;2011:258791.CrossRefPubMedPubMedCentral Toscanini F, De Leo P, Calcagno G, Malfatti F, Grasso A, Anselmo M. Hepatitis B Reactivation in a HBsAg-negative, HBcAb-positive patient receiving Fludarabine for the treatment of chronic lymphocytic Leukaemia. Case Reports Hepatol. 2011;2011:258791.CrossRefPubMedPubMedCentral
13.
go back to reference Appleby N, Dillon A, Arrigan M, Fennell J, Crowley B, Hayden PJ, Enright H. Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma. 2014;55(5):1181–3.CrossRefPubMed Appleby N, Dillon A, Arrigan M, Fennell J, Crowley B, Hayden PJ, Enright H. Symptomatic BK virus reactivation following fludarabine, cyclophosphamide and rituximab chemotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma. 2014;55(5):1181–3.CrossRefPubMed
14.
go back to reference Mercadal S, Martinez A, Nomdedeu B, Rozman M, Gaya A, Salamero O, Campo E. Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine. Eur J Haematol. 2006;77(5):442–4.CrossRefPubMed Mercadal S, Martinez A, Nomdedeu B, Rozman M, Gaya A, Salamero O, Campo E. Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine. Eur J Haematol. 2006;77(5):442–4.CrossRefPubMed
15.
go back to reference Pyatt N, Mitra S. Cytomegalovirus oesophagitis following treatment with fludarabine for refractory lymphoplasmacytic lymphoma. BMJ Case Rep. 2012;2012. Pyatt N, Mitra S. Cytomegalovirus oesophagitis following treatment with fludarabine for refractory lymphoplasmacytic lymphoma. BMJ Case Rep. 2012;2012.
16.
go back to reference Ronan BA, Agrwal N, Carey EJ, De Petris G, Kusne S, Seville MT, Blair JE, Vikram HR. Fulminant hepatitis due to human adenovirus. Infection. 2014;42(1):105–11.CrossRefPubMed Ronan BA, Agrwal N, Carey EJ, De Petris G, Kusne S, Seville MT, Blair JE, Vikram HR. Fulminant hepatitis due to human adenovirus. Infection. 2014;42(1):105–11.CrossRefPubMed
Metadata
Title
Case report: a fatal case of disseminated adenovirus infection in a non-transplant adult haematology patient
Authors
Michael Joffe
Simon D. Wagner
Julian W. Tang
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-2962-7

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue